8-K: Ryan Specialty Reports Strong First Quarter 2025 Results, Revenue Up 25%

Ryan Specialty Holdings, Inc. announced a 25% year-over-year increase in total revenue for the first quarter of 2025, driven by organic growth and contributions from acquisitions.

Summary

• Ryan Specialty Holdings, Inc. reported its first quarter 2025 financial results on May 1, 2025.
• Total revenue increased by 25.0% year-over-year to $690.2 million.
• Organic revenue growth was 12.9% for the quarter.
• Net income decreased to a loss of $(4.4) million, or $(0.22) per diluted share.
• Adjusted EBITDAC grew by 27.5% year-over-year to $200.5 million.
• Adjusted net income increased by 13.0% year-over-year to $107.8 million.
• Adjusted diluted earnings per share grew by 11.4% to $0.39.
• The company is maintaining its full year 2025 outlook for organic revenue growth rate between 11.0% and 13.0%.
• The company is maintaining its full year 2025 outlook for Adjusted EBITDAC Margin guidance for full year 2025 is between 32.5% and 33.5%.

Sentiment

Score: 8

Explanation: The report is generally positive, highlighting strong revenue and earnings growth. While there was a net loss, it was attributed to a non-recurring item. The company's outlook for the year remains positive.

Positives

• The company experienced growth across the majority of its casualty lines and modest growth in property.
• The company's diverse product and services offering, durable business model, and the resiliency of the specialty and E&S markets are expected to help navigate the current challenging macro environment.
• The company believes it has a tremendous runway to deliver sustainable growth over the long term, and to create additional value for its shareholders.

Negatives

• Net income decreased $45.1 million year-over-year to a loss of $(4.4) million.
• The decrease was mainly due to higher Income tax expense during the period related to the legal entity reorganization associated with and subsequent to the Velocity acquisition, which is non-recurring and non-cash.

Risks

• The report contains forward-looking statements that involve substantial risks and uncertainties.
• Risks include the company's ability to achieve anticipated financial results, risks associated with acquisitions, divestitures, joint ventures and strategic investments, outcomes of legal and regulatory matters, and changes in legislation or regulations.

Future Outlook

The company is maintaining its full year 2025 outlook for Organic Revenue Growth Rate between 11.0% and 13.0% and Adjusted EBITDAC Margin between 32.5% and 33.5%.

Management Comments

• Patrick G. Ryan, Founder and Executive Chairman, stated that it was a strong start to 2025 and that the company continues to deliver innovative solutions.
• Tim Turner, Chief Executive Officer, added that the company picked up nicely from the close of 2024 and remains confident in navigating the current challenging macro environment.

Industry Context

Ryan Specialty operates in the specialty insurance market, which is generally more resilient than the broader insurance market. The company's focus on providing innovative solutions and its diverse product and service offerings position it well to capitalize on growth opportunities within this market.

Comparison to Industry Standards

• Comparing Ryan Specialty's organic growth rate of 12.9% to peers like Brown & Brown (typically in the mid-single digits) and Aon (also generally lower), Ryan Specialty demonstrates a strong ability to generate organic revenue.
• The Adjusted EBITDAC margin of 29.1% is competitive within the industry, although companies like Marsh & McLennan might have slightly higher margins due to different business mixes.
• Ryan Specialty's focus on specialty insurance lines allows it to command higher commissions and fees compared to standard insurance brokerage firms.

Stakeholder Impact

• Shareholders will benefit from the declared quarterly dividend of $0.12 per share.
• Employees may benefit from the company's continued growth and success.
• Clients and trading partners can expect continued innovative solutions from Ryan Specialty.

Next Steps

• The company will hold a conference call to discuss the financial results.
• Investors can access the webcast replay on the company's website.

Key Dates

Keywords

Ryan Specialty, financial results, insurance, revenue, EBITDAC, organic growth, dividends, earnings